Loading... Please wait...

Crinetics Pharmaceuticals, Inc. (CRNX) Insider Traders

Currency in USD Disclaimer
$43.83 -$0.37 (-0.84%)
$43.78
$44.42
$15.76
$53.7
  • NUMBER OF INSIDERS BUYING
    (LAST 12 MONTHS)

    0
  • NUMBER OF INSIDERS SELLING
    (LAST 12 MONTHS)

    8
  • AMOUNT OF INSIDERS BUYING
    (LAST 12 MONTHS)

    $0
  • AMOUNT OF INSIDERS SELLING
    (LAST 12 MONTHS)

    $22.30 M

Crinetics Pharmaceuticals, Inc. Insider Trades History


Insider Name Buy/Sell Shares Bought/Sold
@ Price
Total Transaction Shares Held After Transaction Transaction Date Filing Date Details
Knight Jeff E.

COO

Sell 956 @ $44.38 $42,427 52,580 06/26/2024 06/28/2024
Betz Stephen F.

Chief Scientific Officer

Sell 3,000 @ $45.37 $136,110 80,643 06/25/2024 06/26/2024
Pizzuti Dana

Chief Med and Dev Officer

Sell 9,500 @ $45.73 $434,435 27,786 06/24/2024 06/25/2024
Hassard James

Chief Commercial Officer

Sell 15,000 @ $44.66 $669,900 29,259 06/21/2024 06/24/2024
Betz Stephen F.

Chief Scientific Officer

Sell 3,000 @ $43.86 $131,580 83,643 06/10/2024 06/11/2024
Betz Stephen F.

Chief Scientific Officer

Sell 3,000 @ $47.49 $142,470 86,643 05/28/2024 05/30/2024
Betz Stephen F.

Chief Scientific Officer

Sell 3,000 @ $49.43 $148,290 89,643 05/10/2024 05/14/2024
Struthers Richard Scott

CEO

Sell 107,448 @ $49.40 $5.31 M 257,485 05/08/2024 05/10/2024
Pizzuti Dana

Chief Med and Dev Officer

Sell 14,375 @ $44.47 $639,256 27,786 04/15/2024 04/17/2024
Struthers Richard Scott

CEO

Sell 40,951 @ $49.17 $2.01 M 237,835 04/04/2024 04/08/2024
Okey Stephanie

director

Sell 17,500 @ $46.38 $811,650 6,000 03/28/2024 04/02/2024
Knight Jeff E.

COO

Sell 30,000 @ $44.22 $1.33 M 54,939 03/22/2024 03/26/2024
Knight Jeff E.

COO

Sell 2,359 @ $45.39 $107,075 52,580 03/22/2024 03/26/2024
Pizzuti Dana

Chief Med and Dev Officer

Sell 10,000 @ $43.28 $432,800 28,500 03/20/2024 03/22/2024
Pizzuti Dana

Chief Med and Dev Officer

Sell 4,375 @ $45.89 $200,769 28,500 03/20/2024 03/22/2024
Pizzuti Dana

Chief Med and Dev Officer

Sell 714 @ $43.69 $31,195 27,786 03/20/2024 03/22/2024
Fust Matthew K

director

Sell 17,500 @ $43.58 $762,650 18,536 03/20/2024 03/22/2024
Fust Matthew K

director

Sell 12,500 @ $43.57 $544,625 18,536 03/20/2024 03/22/2024
Wilson Marc

CFO

Sell 6,942 @ $42.91 $297,881 110,630 03/19/2024 03/20/2024
Betz Stephen F.

Chief Scientific Officer

Sell 3,000 @ $37.26 $111,780 73,298 01/25/2024 01/26/2024

Crinetics Pharmaceuticals, Inc. Congressional Trades History


Member of congress Current Price Type Trade Data Date Filed Date Traded

Crinetics Pharmaceuticals, Inc. Insider Trading Activity - Frequently Asked Questions

  • Q.Who is on Crinetics Pharmaceuticals, Inc.'s Insider Roster?

    A. The list of insiders at Crinetics Pharmaceuticals, Inc. includes Wilson Marc, Struthers Richard Scott, Betz Stephen F., Pizzuti Dana, Fust Matthew K, Knight Jeff E., Okey Stephanie, Hassard James.

  • Q.How much insider selling is happening at Crinetics Pharmaceuticals, Inc.?

    A. Insiders have sold a total of 561,078 Crinetics Pharmaceuticals, Inc. shares in the last 12 months for a total of 22.30 M sold.

  • Q.Which Crinetics Pharmaceuticals, Inc. insiders have been selling company stock?

    A. The following insiders have sold Crinetics Pharmaceuticals, Inc. shares in the last 12 months: Wilson Marc ($940,081), Struthers Richard Scott ($13.43 M), Betz Stephen F. ($1.08 M), Pizzuti Dana ($2.57 M), Fust Matthew K ($1.31 M), Knight Jeff E. ($1.48 M), Okey Stephanie ($811,650), Hassard James ($669,900),

×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.